ScreenerHero

PULM Pulmatrix, Inc.

NAS · US · Healthcare · Biotechnology · pulmatrix.com
1.527USD+2.49%Mkt Cap: 5.58M $P/E: —

Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.47BUSDP/E 29.3
MRNA
Moderna, Inc.
$78.65BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.14BUSDP/E 18.3
ARGX
argenx SE
$51.48BUSDP/E 31.2
ARGX
argenx SE
$48.23BUSDP/E 31.4
UCB
UCB SA
$41.82BUSDP/E 17.8
RVMD
Revolution Medicines, Inc.
$40.32BUSD
ONC
BeOne Medicines AG
$39.83BUSDP/E 62.6
RPRX
Royalty Pharma plc
$32.48BUSDP/E 29.9
ALNY
Alnylam Pharmaceuticals, Inc.
$30.04BUSDP/E 37.9
ROIV
Roivant Sciences Ltd.
$24.71BUSD
BNTX
BioNTech SE
$23.13BUSD
INCY
Incyte Corporation
$22.85BUSDP/E 14.4
GMAB
Genmab A/S
$22.17BUSDP/E 28.4
INSM
Insmed Incorporated
$21.94BUSD
GMAB
Genmab A/S
$21.10BUSDP/E 29.1
ASND
Ascendis Pharma A/S
$14.65BUSDP/E 17.1
EXEL
Exelixis, Inc.
$14.62BUSDP/E 18.6
JAZZ
Jazz Pharmaceuticals plc
$14.44BUSDP/E 15.2
SMMT
Summit Therapeutics Inc.
$13.70BUSD

Key Statistics

Company
Market Cap5.58M USD
Enterprise Value4.02M USD
Revenue (TTM)—
Gross Profit-38.00K USD
Net Income (TTM)-5.16M USD
Revenue/Share—
Last Price1.527 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.32
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B3.28
EPS (TTM)-1.10
EPS (Forward)-4.50
52W Range
1.1608% of range5.498
52W High5.498 USD
52W Low1.160 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-135.49%
ROA-124.72%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.43M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-56.78%
Net Debt-2.17M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio4.70
Quick Ratio3.15
Book Value/Sh0.44 USD
Cash/Share0.59 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay DateFeb 6, 2019
Splits
Last Split1:20
Split DateMar 1, 2022
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.3.65M
Float3.65M
Insiders0.78%
Institutions9.16%
Short Interest
Short Ratio2.0d
Short % Float1.53%
Short % Out.1.52%
Shares Short55.39K
Short (prev mo.)4.17K
Technical
SMA 501.555 (-1.8%)
SMA 2001.808 (-15.5%)
Beta1.93
S&P 52W Chg16.45%
Avg Vol (30d)28.87K
Avg Vol (10d)27.19K
Technical Indicators
RSI (14)49.6
MACD-0.0102
MACD Signal-0.0057
MACD Hist.-0.0044
BB Upper1.706 USD
BB Middle1.522 USD
BB Lower1.339 USD
BB Width24.09%
ATR (14)0.1056 USD
Vol Ratio (20d)0.36x